NASDAQ: TLX
Telix Pharmaceuticals Ltd Stock Ownership - Who owns Telix Pharmaceuticals?

Insider buying vs selling

Have Telix Pharmaceuticals Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christian BehrenbruchMD Group CEO2026-04-2933,435$14.87
$497.18kBuy
Christian BehrenbruchMD Group CEO2026-04-2834,500$14.48
$499.56kBuy

1 of 1

TLX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TLX insiders and whales buy or sell their stock.

TLX Shareholders

What type of owners hold Telix Pharmaceuticals Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Christian Behrenbruch6.20%20,996,941$198.42MInsider
Mark Alexander Nelson1.07%3,628,750$34.29MInsider
Jann Elizabeth Skinner0.18%595,000$5.62MInsider
Fmr LLC0.17%564,757$5.34MInstitution
Portolan Capital Management LLC0.16%541,267$5.11MInstitution
David Norman Cade0.11%373,133$3.53MInsider
Lazard Asset Management LLC0.09%289,917$2.74MInstitution
Portland Investment Counsel Inc0.08%266,200$2.52MInstitution
Private Advisor Group LLC0.05%174,415$1.65MInstitution
Integrated Wealth Concepts LLC0.05%164,397$1.55MInstitution

1 of 3

TLX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TLX0.76%7.56%Net BuyingNet Buying
VKTX63.02%8.85%Net Selling
ALMS77.18%22.82%Net BuyingNet Buying
ARQT77.57%22.43%Net SellingNet Selling
GPCR31.31%10.35%Net Selling

Telix Pharmaceuticals Stock Ownership FAQ

Who owns Telix Pharmaceuticals?

Telix Pharmaceuticals (NASDAQ: TLX) is owned by 0.76% institutional shareholders, 7.56% Telix Pharmaceuticals insiders, and 91.68% retail investors. Christian Behrenbruch is the largest individual Telix Pharmaceuticals shareholder, owning 21.00M shares representing 6.20% of the company. Christian Behrenbruch's Telix Pharmaceuticals shares are currently valued at $200.73M.

If you're new to stock investing, here's how to buy Telix Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.